OBJECTIVE:Elderly heart failure patients are at high risk of events. Available studies and systematic reviews suggest that elderly patients benefit from disease management programmes (DMPs). However, important questions remain open, including the optimal follow-up intensity and duration and whether such interventions are cost-effective during long-term follow-up and in different healthcare systems. The aim of this study was to determine the long-term efficacy of a hybrid DMP in consecutive older outpatients. METHODS:Intervention consisted in combined hospital-based (cardiologists and nurse-coordinators from two heart failure clinics) and home-based (patient's general practitioner visits) care. The components of the DMP were the following: discharge planning, education, therapy optimisation, improved communication, early attention to signs and symptoms. Intensive follow-up was based on scheduled hospital visits (starting within 14 days of discharge), nurse's phone call and home general practitioner visits. RESULTS: A group of 173 patients aged > or =70 years (mean age 77 +/- 6 years, 48% women) was randomly assigned to DMP (n = 86) or usual care (n = 87). At 2-year follow-up, a 36% reduction in all-cause death and heart failure hospital admissions was observed in DMP vs. usual care. All-cause and heart failure admissions as well as the length of hospital stay were also reduced. DMP patients reported, compared to baseline, significant improvements in functional status, quality of life and beta-blocker prescription rate. The intervention was cost-effective with a mean saving of euro 982.04 per patient enrolled. CONCLUSIONS: A hybrid DMP for elderly heart failure patients improves outcomes and is cost-effective over a long-term follow-up.
RCT Entities:
OBJECTIVE: Elderly heart failurepatients are at high risk of events. Available studies and systematic reviews suggest that elderly patients benefit from disease management programmes (DMPs). However, important questions remain open, including the optimal follow-up intensity and duration and whether such interventions are cost-effective during long-term follow-up and in different healthcare systems. The aim of this study was to determine the long-term efficacy of a hybrid DMP in consecutive older outpatients. METHODS: Intervention consisted in combined hospital-based (cardiologists and nurse-coordinators from two heart failure clinics) and home-based (patient's general practitioner visits) care. The components of the DMP were the following: discharge planning, education, therapy optimisation, improved communication, early attention to signs and symptoms. Intensive follow-up was based on scheduled hospital visits (starting within 14 days of discharge), nurse's phone call and home general practitioner visits. RESULTS: A group of 173 patients aged > or =70 years (mean age 77 +/- 6 years, 48% women) was randomly assigned to DMP (n = 86) or usual care (n = 87). At 2-year follow-up, a 36% reduction in all-cause death and heart failure hospital admissions was observed in DMP vs. usual care. All-cause and heart failure admissions as well as the length of hospital stay were also reduced. DMPpatients reported, compared to baseline, significant improvements in functional status, quality of life and beta-blocker prescription rate. The intervention was cost-effective with a mean saving of euro 982.04 per patient enrolled. CONCLUSIONS: A hybrid DMP for elderly heart failurepatients improves outcomes and is cost-effective over a long-term follow-up.
Authors: Esther S Park; Marie R Peccoud; Kay A Wicks; Jeffrey B Halldorson; Robert L Carithers; Jorge D Reyes; James D Perkins Journal: J Am Med Inform Assoc Date: 2010 Jul-Aug Impact factor: 4.497
Authors: Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth Journal: Can J Cardiol Date: 2010-04 Impact factor: 5.223
Authors: Anja Neumann; Sarah Mostardt; Janine Biermann; Götz Gelbrich; Alexander Goehler; Benjamin P Geisler; Uwe Siebert; Stefan Störk; Georg Ertl; Christiane E Angerrmann; Jürgen Wasem Journal: Clin Res Cardiol Date: 2014-11-18 Impact factor: 5.460
Authors: D Phelan; L Smyth; M Ryder; N Murphy; C O'Loughlin; C Conlon; M Ledwidge; K McDonald Journal: Ir J Med Sci Date: 2009-05-01 Impact factor: 1.568
Authors: Kimberly Smith; Melinda Coston; Kimberly Glock; Tom A Elasy; Kenneth A Wallston; T Alp Ikizler; Kerri L Cavanaugh Journal: J Ren Nutr Date: 2009-11-13 Impact factor: 3.655
Authors: Nicholas Graves; Mary Courtney; Helen Edwards; Anne Chang; Anthony Parker; Kathleen Finlayson Journal: PLoS One Date: 2009-10-14 Impact factor: 3.240